<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>   <meta charset="utf-8" />
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 10">
<meta name=Originator content="Microsoft Word 10">
<link rel=File-List href="travma_dosyalar/filelist.xml">
<link rel=Edit-Time-Data href="travma_dosyalar/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>G�n�m�zde Kafa Travmas&#305;na</title>
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:35.4pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:12.0pt;
	font-family:"Times New Roman";
	text-decoration:underline;
	text-underline:single;}
h2
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:42.55pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:normal;
	font-style:italic;
	text-decoration:underline;
	text-underline:single;}
h3
	{margin:0cm;
	margin-bottom:.0001pt;
	text-indent:35.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";}
h4
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:35.4pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:"Times New Roman";}
h5
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:42.55pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:11.0pt;
	font-family:"Times New Roman";}
h6
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:42.55pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:"Times New Roman";
	text-decoration:underline;
	text-underline:single;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	mso-outline-level:9;
	font-size:11.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:150%;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:150%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:42.55pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:35.4pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:42.55pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.char
	{mso-style-name:char;
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
span.char0
	{mso-style-name:char0;
	font-style:italic;
	text-decoration:underline;
	text-underline:single;}
span.char1
	{mso-style-name:char1;
	font-weight:bold;}
span.char2
	{mso-style-name:char2;
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
span.msons
	{mso-style-name:mso\0131ns;
	text-decoration:underline;
	text-underline:single;}
span.msodel0
	{mso-style-name:msodel;
	color:red;
	text-decoration:line-through;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:70.85pt 70.85pt 70.85pt 70.85pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Normal Tablo";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";}
</style>
<![endif]-->
</head>

<body lang=EN-US link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoTitle><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></p>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoTitle align=left style='text-align:left'><span lang=TR
style='font-size:18.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>Kafa Travmas&#305;</span></p>

<p class=MsoTitle align=left style='text-align:left;line-height:normal'><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Aykut Karasu, Altay
Sencer </span></p>

<p class=MsoNormal><span lang=TR style='font-size:10.0pt;font-family:Tahoma;
mso-ansi-language:TR'>&#304;.�. &#304;stanbul T&#305;p Fak�ltesi,
N�ro&#351;ir�rji Anabilim Dal&#305;</span></p>

<p class=MsoNormal><span lang=TR style='font-size:14.0pt;font-family:Tahoma;
mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Son G�ncelle&#351;tirme tarihi:<b> 16.07.2009<o:p></o:p></b></span></p>

<p class=MsoNormal align=right style='text-align:right'><b><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:75pt;
 height:90pt'>
 <v:imagedata src="travma_dosyalar/image001.jpg" o:title="aykutkarasu"/>
</v:shape><![endif]--><![if !vml]><img width=100 height=120
src="travma_dosyalar/image001.jpg" v:shapes="_x0000_i1025"><![endif]><o:p></o:p></span></b></p>

<p class=MsoNormal align=right style='text-align:right'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Tahoma'>Dr. Aykut Karasu<o:p></o:p></span></b></p>

<p class=MsoNormal align=right style='text-align:right'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Tahoma'>1963-2009<o:p></o:p></span></b></p>

<p class=MsoNormal align=right style='text-align:right'><i style='mso-bidi-font-style:
normal'>Sayg&#305; ile<o:p></o:p></i></p>

</div>

<p class=MsoTitle align=left style='text-align:left'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-size:14.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>Epidemiyoloji</span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Son y&#305;llarda
a&#287;&#305;r kafa travmas&#305;na ba&#287;l&#305; mortalite oranlar&#305;
belirgin bir d�&#351;�&#351; g�stererek % 20-30�lara kadar gerilemi&#351;tir.
Yine de, Kuzey Amerika verilerine g�re y&#305;lda yakla&#351;&#305;k 150000
ki&#351;i travma nedeniyle hayat&#305;n&#305; kaybetmektedir ve bu �l�mlerin
yakla&#351;&#305;k 1/3�� kafa travmas&#305;na ba&#287;l&#305;d&#305;r.
Ayn&#305; konudaki �al&#305;&#351;malar, sadece kafa travmas&#305; nedeniyle,
y&#305;lda yakla&#351;&#305;k 80000 ki&#351;inin sakat
kald&#305;&#287;&#305;n&#305; g�stermektedir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-size:14.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>S&#305;n&#305;fland&#305;rma</span></b><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>G�n�m�zde en s&#305;k kullan&#305;lan s&#305;n&#305;fland&#305;rmalar, kafa
travmas&#305;n&#305;, a&#287;&#305;rl&#305;&#287;&#305;na g�re ay&#305;r&#305;r
ve bunun i�in Glasgow Koma Skalas&#305;n&#305; (GKS) temel al&#305;r
(Bak&#305;n&#305;z:<span style='color:blue'> <u><a href="../semi2/koma.htm">Koma
ve Komal&#305; Hastan&#305;n Muayenesi</a></u></span>). &#304;lk defa
Teasdale�in 1974�te �nerdi&#287;i, bug�n hem Kuzey Amerika ve Avrupa�da, hem de
�lkemizde yayg&#305;n olarak kullan&#305;lan bu skala, hastan&#305;n hem ilk,
hem sonraki de&#287;erlendirmelerinde, tedavinin y�nlendirilmesinde ve
prognozun belirlenmesinde yarar&#305;n&#305; ve
kullan&#305;&#351;l&#305;l&#305;&#287;&#305;n&#305; ispat etmi&#351;tir.
Kardiyopulmoner res�sitasyondan �nceki de&#287;erlendirmenin
yan&#305;lt&#305;c&#305; olabilmesi, alkol gibi sedatif-hipnotik
alm&#305;&#351; olanlarda ya da farmakolojik sedasyon ve paralizi uygulananlarda
de&#287;erlendirmenin g��le&#351;mesi gibi, bu skalaya �zg�
dezavantajlar&#305;n, beyinsap&#305; refleksleri, BT g�r�nt�leme bulgular&#305;
ve klinik gidi&#351;at&#305;n takibi gibi fakt�rlerle ortadan
kald&#305;r&#305;lmas&#305; m�mk�nd�r. �ocuklar i�in ise, GKS�yi temel alan
�zel skalalar �retilmi&#351;tir.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Yukar&#305;da da belirtildi&#287;i gibi, GKS�n&#305;n say&#305;sal
de&#287;erleri do&#287;rultusunda kafa travmalar&#305;,
a&#287;&#305;rl&#305;&#287;&#305;na g�re, hafif, orta ve a&#287;&#305;r
&#351;eklinde s&#305;n&#305;fland&#305;r&#305;lm&#305;&#351;t&#305;r:</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText><b><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></i></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText><b><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Hafif Kafa Travmas&#305;&nbsp; </span></i></b><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Beyin i&#351;levlerinde a&#351;a&#287;&#305;da belirtilen &#351;ekillerde
bir de&#287;i&#351;ime yol a�an travmalar hafif (ya da baz&#305; kaynaklarda
belirtildi&#287;i �zere, min�r) kafa travmas&#305; olarak
s&#305;n&#305;fland&#305;r&#305;lm&#305;&#351;t&#305;r:</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Symbol;mso-ansi-language:TR'>�</span><span lang=TR
style='font-size:7.0pt;line-height:150%;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&#304;spatlanm&#305;&#351;
ge�ici bilin� kayb&#305; (be&#351; dakikadan k&#305;sa)</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Symbol;mso-ansi-language:TR'>�</span><span lang=TR
style='font-size:7.0pt;line-height:150%;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Olay&#305;n
�ncesine veya sonras&#305;na ait bellek kayb&#305;</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Symbol;mso-ansi-language:TR'>�</span><span lang=TR
style='font-size:7.0pt;line-height:150%;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;Travma
s&#305;ras&#305;nda somnolans, konf�zyon veya dezoryantasyon &#351;eklinde
bilin� de&#287;i&#351;iklikleri</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Symbol;mso-ansi-language:TR'>�</span><span lang=TR
style='font-size:7.0pt;line-height:150%;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>GKS�nin 14
veya 15 olmas&#305;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Symbol;mso-ansi-language:TR'>�</span><span lang=TR
style='font-size:7.0pt;line-height:150%;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Hemiparezi
gibi bir fokal n�rolojik bulgunun olmamas&#305;</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:36.0pt;text-indent:-18.0pt'><span
lang=TR style='font-family:Symbol;mso-ansi-language:TR'>�</span><span lang=TR
style='font-size:7.0pt;line-height:150%;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>24 saati
ge�meyen posttravmatik amnezi</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Ku&#351;kusuz yukar&#305;da belirtilen kriterler kesin de&#287;ildir. Kimi
kaynaklar GKS�si 13 olan hastalar&#305; da hafif kafa travmas&#305; i�ine
al&#305;rken, baz&#305;lar&#305; da, GKS�si 15 olan, bilin� kayb&#305; veya
postravmatik amnezisi olmayan hastalar&#305; dahil ettikleri, �minimal kafa
travmas&#305;� ad&#305; alt&#305;nda bir alt kategori olu&#351;turmu&#351;tur.
Burada as&#305;l �nemli olan hafif kafa travmas&#305;n&#305;n klinik bir
tan&#305; oldu&#287;u ve BT gibi g�r�nt�leme y�ntemleri ya da laboratuar
sonu�lar&#305; ile ilgisi olmad&#305;&#287;&#305;d&#305;r. Sonu� olarak hafif
kafa travmas&#305;, kesinlikle ihmal edilmemesi, incelenmesi ve takip edilmesi
gereken bir durumdur. Minimal kafa travmas&#305; olan hastalarda bile ge�
semptomatik, kognitif sekeller bildirilmi&#351;tir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:27.0pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp; </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><b><i><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Orta &#350;iddette Kafa Travmas&#305;</span></i></b><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>GKS puan&#305; 9 � 13 aras&#305; de&#287;erlendirilen hastalar orta
&#351;iddette kafa travmas&#305; olarak s&#305;n&#305;fland&#305;r&#305;l&#305;r.
Hafif kafa travmalar&#305;na oranla bu hastalarda kont�zyon veya diff�z aksonal
hasar gibi lezyonlar daha s&#305;k g�r�l�r. Yine epidural ya da subdural
hematom ve kafa i�i bas&#305;n� art&#305;&#351;&#305; sendromu (K&#304;BAS)
gibi komplikasyonlar&#305;n ortaya �&#305;kma olas&#305;l&#305;&#287;&#305;
daha fazlad&#305;r. Bu nedenle bu hastalar, bir yo&#287;un bak&#305;m �nitesine
al&#305;narak, yak&#305;ndan izlenmelidir. Prognozun genelde iyi olmas&#305;na
kar&#351;&#305;l&#305;k, uzun d�nemde kognitif sekeller veya posttravmatik
epilepsi gibi komplikasyonlar g�r�lebilir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:27.0pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp; </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><i><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>A&#287;&#305;r Kafa
Travmas&#305;</span></i></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&#304;lk muayenede GKS
puan&#305; 8 veya daha d�&#351;�k olan hastalar a&#287;&#305;r kafa
travmal&#305; olarak s&#305;n&#305;fland&#305;r&#305;l&#305;r. G�z a�mayan,
konu&#351;amayan, emirlere uymayan bu hastalar �komada� olarak kabul
edilebilir. Bu de&#287;erlendirmede, motor muayene prognoz a�&#305;s&#305;ndan
di&#287;erlerine g�re daha b�y�k �nem ta&#351;&#305;r. A&#287;r&#305;l&#305;
uyaran&#305; lokalize eden hastalar&#305;n hayatta kalma ve iyile&#351;me
&#351;anslar&#305; ekstans�r yan&#305;t verenlere veya hi� yan&#305;t&#305;
olmayanlara g�re �ok daha fazlad&#305;r. Yine, beyinsap&#305; refleksleri,
�zellikle de pupillalar&#305;n &#305;&#351;&#305;&#287;a yan&#305;t&#305;,
prognoz a�&#305;s&#305;ndan �ok de&#287;erlidir. </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-size:14.0pt;line-height:150%;font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-size:14.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>Fizyopatoloji </span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Kafa travmas&#305;n&#305;n
fizyopatolojisi primer (birincil) ve sekonder (ikincil) beyin
hasar&#305;n&#305;n iyi anla&#351;&#305;lmas&#305;na dayan&#305;r. Primer
hasar, cilt, cilt alt&#305;, kafatas&#305; ve beyinde travma an&#305;nda
olu&#351;an zarar&#305; g�sterir. Bunlar&#305;n yol a�t&#305;&#287;&#305;
fizyolojik ve metabolik bozukluklar nedeniyle, beyinde travma sonras&#305; ilk
birka� g�nde geli&#351;en iskemi, �dem ve K&#304;BAS gibi durumlar sonucunda
sonradan geli&#351;en zararlar ise sekonder beyin hasar&#305; olarak nitelendirilir.
Son 20 y&#305;lda yap&#305;lan deneysel ve klinik �al&#305;&#351;malar&#305;n
�nemli bir b�l�m� sekonder hasar&#305;n anla&#351;&#305;lmas&#305;na ve
�nlenmesine odaklanm&#305;&#351; ve bu alanda kaydedilen geli&#351;meler klinik
tedavinin y�nlendirilmesinde b�y�k katk&#305; sa&#287;lam&#305;&#351;t&#305;r.
Gelecekte de, kafa travmas&#305;n&#305;n patofizyolojisini daha da iyi anlamam&#305;za
y�nelik h�cre biyokimyas&#305; ve geneti&#287;i d�zeyindeki
�al&#305;&#351;malar, yeni tedavi &#351;ekillerinin ortaya
�&#305;kmas&#305;n&#305; sa&#287;layacakt&#305;r.<b> </b></span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Travma
mekanizmalar&#305;: </span></b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'>Dokunma kuvvetlerinin veya at&#305;l kuvvetlerin beyin,
kafatas&#305; ve cilt-cilt alt&#305; gibi dokularda toleranslar&#305;n&#305;n
�zerinde gerilmeye yol a�mas&#305; ile bu dokularda hasar olu&#351;ur. Dokunma
kuvvetleri hemen �arpman&#305;n kom&#351;ulu&#287;unda cilt ve cilt alt&#305;
laserasyonlar&#305;, kemik k&#305;r&#305;klar&#305;, ve serebral kont�zyonlar
olu&#351;tururken; at&#305;l kuvvetler translasyonel, rotasyonel veya ang�ler
olup ani akselerasyon/deselerasyon ile kafa travmas&#305;na neden olur.
Kafatas&#305; ve beynin yo&#287;unluklar&#305; farkl&#305; oldu&#287;undan, bu
at&#305;l kuvvetler, beynin kafatas&#305; i�erisinde hareket etmesine ve
frontal ve temporal loblar gibi, daha �ok d�zensiz kemik y�zeylerine kom&#351;u
beyin b�lgelerinde akselerasyon/deselerasyon sonucu kont�zyonlar
olu&#351;mas&#305;na neden olur. Beyinle dura aras&#305;ndaki k�pr� venler
y&#305;rt&#305;larak subdural hematomlar olu&#351;abilir. Rotasyonel
kuvvetlerin ise, gri madde ile ak madde aras&#305;ndaki yo&#287;unluk
fark&#305; nedeniyle, bu ge�i&#351; b�lgesinde diff�z aksonal hasara neden
oldu&#287;u d�&#351;�n�lmektedir. Translasyonel ve rotasyonel kuvvetlerin
kombinasyonundan do&#287;an ang�ler akselerasyonlar ise trafik kazalar&#305;nda
en s&#305;k ortaya �&#305;kan at&#305;l kuvvetlerdir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Primer hasar: </span></b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Cilt ve cilt alt&#305;
yaralanmalar&#305;, kafatas&#305; k&#305;r&#305;klar&#305; (lineer, ��kme, kafa
taban&#305;), intrakranyal kont�zyon ve kanamalar (subaraknoid kanama, epidural
hematom ve subdural hematom) ve diff�z aksonal hasar (DAH) gibi travma
an&#305;nda olu&#351;an yaralanmalar primer hasar olarak adland&#305;r&#305;l&#305;r.
DAH, yukar&#305;da da de&#287;inildi&#287;i gibi, rotasyonal akselerasyon/
deselerasyon kuvvetlerinin etkisiyle aksonlarda hasar ile ortaya �&#305;kan,
histopatolojik bir tan&#305;d&#305;r. Subkortikal ak maddeden (hafif form), korpus
kallozum ve beyinsap&#305;na dek (en a&#287;&#305;r form) beynin her yerinde
yayg&#305;n olarak g�r�lebilir ve genellikle k�t� prognozlu, a&#287;&#305;r
kafa travmas&#305;n&#305;n habercisidir. Erken d�nem BT incelemelerinde pek
bulgu vermedi&#287;inden (bazen derin yerle&#351;imli birka� ufak kont�zyon),
kafa travmas&#305; ge�irmi&#351;, &#351;uuru kapal&#305;, BT�sinde (serebral
�dem dahil) bunu a�&#305;klayacak lezyon olmayan hastalarda mutlaka akla
gelmelidir. Bu hastalarda kesin tan&#305; beyin MR incelemesi yap&#305;larak
subkortikal ak madde, korpus kallozum ve beyinsap&#305;nda T2 ve FLAIR
sekenslarda hiperintens odaklar&#305;n saptanmas&#305; ile m�mk�nd�r.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Sekonder hasar:</span></b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'> Son 20
y&#305;ld&#305;r �e&#351;itli deneysel ve klinik ara&#351;t&#305;rmalara konu
olan ve �nemi giderek artan iskemi, eksitotoksisite, iyon homeostaz&#305;nda
bozulma, genetik farkl&#305;l&#305;klar ve iltihabi yan&#305;t gibi fizyolojik
ve metabolik mekanizmalarla ortaya �&#305;kan beyin kan ak&#305;m&#305;nda
azalma, beyin �demi ve K&#304;BAS, sekonder beyin hasar&#305;n&#305;
olu&#351;turur. &#304;lk travmadan saatler, bazen g�nler sonra ortaya
�&#305;kabilece&#287;i i�in, sekonder beyin hasar&#305;n&#305; ve buna
ba&#287;l&#305; n�ron kayb&#305;n&#305; azaltmak teorik olarak m�mk�nd�r ve
g�n�m�zde travma mahallinde ba&#351;lay&#305;p yo&#287;un bak&#305;m �nitesinde
devam eden tedavi protokollerinden �o&#287;u buna y�neliktir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<h1 style='text-indent:0cm'><span lang=TR style='font-size:14.0pt;line-height:
150%;font-family:Tahoma;mso-ansi-language:TR;text-decoration:none;text-underline:
none'>Klinik Muayene ve Radyolojik De&#287;erlendirme</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></h1>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent2 style='text-indent:0cm'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>�zellikle a&#287;&#305;r kafa
travmas&#305;nda, travma an&#305;ndan yaral&#305;n&#305;n tam te&#351;ekk�ll�
bir merkeze nakline dek ge�en s�re �ok �nemlidir. Bu s�re zarf&#305;nda hastada
solunum yollar&#305;n&#305;n, solunum sisteminin ve hemodinaminin
stabilizasyonunun sa&#287;lanmas&#305;n&#305;n sekonder hasar&#305; �nleyerek,
hem mortalite hem de morbiditenin azalt&#305;lmas&#305;nda �nemli rol
oynad&#305;&#287;&#305;; tam tersine hipotansiyon ve hipooksijenasyonun
�nlenememesi durumunda mortalitenin %80�lere y�kseldi&#287;i bildirilmektedir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent2><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent2 style='text-indent:0cm'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Ya&#351;amsal
fonksiyonlar&#305;n g�venceye al&#305;nmas&#305;n&#305;n ard&#305;ndan, travma
hastas&#305;n&#305;n ayr&#305;nt&#305;l&#305; v�cut muayenesi
ger�ekle&#351;tirilir. En iyisi, bunu, olay yerindeki ilk yard&#305;mdan sonra,
ambulansta yapmakt&#305;r. Bu a&#351;amada, �ncelikle, Glasgow Koma
Skalas&#305; (GKS) &#305;&#351;&#305;&#287;&#305;nda, bilin� durumu ve
pupillalar, ek olarak da a&#287;r&#305;ya motor ve s�zl� yan&#305;t tekrar
kontrol edilir. Ard&#305;ndan kafatas&#305; muayene edilir: Burun ve
a&#287;&#305;zdan kan gelmesi, �st �enede anormal hareket ve orbita b�lgesinde
deri amfizemi, y�z kemiklerinde k&#305;r&#305;&#287;a i&#351;aret eden
bulgulard&#305;r. A&#287;&#305;r orta kaide k&#305;r&#305;klar&#305;nda doku
i�ine, fark edilmeyen b�y�k kanamalar olabilir. Ayr&#305;ca tek veya iki
tarafl&#305; periorbital (monokl veya g�zl�k tarz&#305;) ekimozlar (rakun
g�z�), d&#305;&#351; kulak yolundan kanamalar ya da kulak arkas&#305;nda ekimoz
(Battle bulgusu) kaide k&#305;r&#305;&#287;&#305; habercisi olabilir. Ard&#305;ndan
omurga, toraks (palpasyon ve osk�ltasyonla), bat&#305;n, pelvis ve ekstremite
muayeneleri gelir. Ayr&#305;ca ciddi kafa travmas&#305;na yakla&#351;&#305;k %6
oran&#305;nda servikal travman&#305;n da e&#351;lik edebilece&#287;i
unutulmamal&#305;, boynun immobilizasyonu ve servikal grafilerin temini ihmal
edilmemelidir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>H&#305;zl&#305; n�rolojik
de&#287;erlendirme ve temel kan testlerinden sonraki ad&#305;m radyolojik
g�r�nt�lemedir. A&#287;&#305;r kafa travmas&#305;nda kranyal bilgisayarl&#305;
tomografinin yeri bug�n art&#305;k tart&#305;&#351;mas&#305;z olarak kabul
edilmi&#351;tir. Koma tablosundaki hastalarda yeti&#351;kinlerde
yakla&#351;&#305;k %46, �ocuklarda da %24 oran&#305;nda cerrahi giri&#351;im
gerektirecek kitle lezyonlar&#305; bulundu&#287;u g�z �n�ne al&#305;n&#305;rsa,
h&#305;zl&#305; bilgisayarl&#305; tomografi (BT) temininin �nemi daha iyi
anla&#351;&#305;l&#305;r. Ayr&#305;ca kranyal BT s&#305;ras&#305;nda C1-C2
seviyesinin de g�r�nt�lenmesi, basit ve yararl&#305; bir i&#351;lemdir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>A&#287;&#305;r koma tablosunda
(GKS=3-4) gelen veya h&#305;zla k�t�le&#351;en hastalara BT �ekimi ile vakit
kaybetmeyip direkt �burr-hole� a�&#305;lmas&#305; zaman zaman g�ndeme
gelmektedir. Ancak cerrahi boyutta bir kitle bulunmas&#305; ihtimalinin
d�&#351;�k olmas&#305; ve di&#287;er tedavi giri&#351;imlerini geciktirmesi,
ayr&#305;ca g�n�m�zde modern merkezlerde BT�nin �ok h&#305;zl&#305; ve kolay
�ekilebilmesi giderek bu y�ntemden uzakla&#351;&#305;lmas&#305;na neden
olmu&#351;tur. Sonu�ta bu i&#351;lem, h&#305;zl&#305; ilerleyen ve fokal bir
lezyona i&#351;aret eden bulgular&#305;n varl&#305;&#287;&#305;nda ve BT�nin
kolay temin edilemedi&#287;i durumlarda bir alternatif olabilir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:35.4pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Di&#287;er bir problem, hafif kafa travmas&#305;nda ne zaman kranyal BT
�ekilmesi gerekti&#287;idir. K&#305;sa s�reli bir bilin� kayb&#305; ile
ba&#351;vuran, GKS=15 olan hastalarda bile yakla&#351;&#305;k % 3-5
oran&#305;nda, cerrahi giri&#351;im gerektirebilecek intrakranyal patolojiler
saptanabilmesi nedeniyle, bu hastalar&#305;n&nbsp; BT ile g�r�nt�lenmesi ya da
en az 12 saat g�zlemde tutulmas&#305; �nerilmektedir. GKS�nin 13��n
alt&#305;nda olmas&#305;, 5 dakikadan uzun bilin� kayb&#305; ve fokal n�rolojik
bulgu ise kesin BT indikasyonlar&#305;d&#305;r. Yine periorbital ekimoz ya da
kulak arkas&#305; morluk (�Battle sign�) gibi olas&#305; �n veya orta kafa
taban&#305; k&#305;r&#305;&#287;&#305;n&#305; d�&#351;�nd�ren bulgular da BT
�ekilmesini gerektirir. Ayr&#305;ca ileri ya&#351; grubundaki hastalarda ve
koag�lopati &#351;�phesinde de BT tercih edilebilir. Bu arada, BT�nin
yayg&#305;n kullan&#305;m&#305; ve ilk tercih edilen g�r�nt�leme y�ntemi haline
gelmesi, kranyografinin de&#287;erini olduk�a yitirmesine ve bir �ok merkez
taraf&#305;ndan kullan&#305;m&#305;na son verilmesine yol a�m&#305;&#351;t&#305;r.
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent2><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent2 style='text-indent:0cm'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Belirgin bilin� kayb&#305;,
ciddi ve &#305;srarl&#305; ba&#351; a&#287;r&#305;s&#305;, &#305;srarl&#305;
kusmalar veya n�bet, �ocuk suistimali ku&#351;kusu, uzam&#305;&#351;
posttravmatik amnezi, patolojik BT bulgular&#305;, delici yaralanmalar, rinore
veya otore, kaide k&#305;r&#305;klar&#305;, BT temininin m�mk�n olmamas&#305;,
hastan&#305;n evden geri getirilmesinin g�� olu&#351;u veya evde yeterli
bak&#305;m ve g�zetimin olmamas&#305; hafif kafa travmal&#305; hastalar i�in
genelde kabul g�ren hastaneye yat&#305;rma kriterlerdir</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:35.4pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>G�n�m�zde kafa travmas&#305;nda manyetik rezonans g�r�nt�leme (MRG),
�zellikle destek tedavi y�ntemlerini ve prognoz belirleme amac&#305;yla giderek
daha s&#305;k kullan&#305;lmaktad&#305;r. MRG�de �zellikle diff�z aksonal hasar
ve benzeri n�ral hasar sonu�lar&#305;n&#305;n ortaya konmas&#305; i�in yeni
sekanslar geli&#351;tirilmekte ve ayn&#305; zamanda MR spektroskopi, MR
perf�zyon �al&#305;&#351;malar&#305; ile beyindeki travmatik hasar&#305;n (yayg&#305;nl&#305;k,
hasar derecesi, vazospazm ve perf�zyon bozukluklar&#305;n&#305;n
varl&#305;&#287;&#305;, vb) daha do&#287;ru olarak ortaya konmas&#305;na
�al&#305;&#351;&#305;lmaktad&#305;r.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:35.4pt;text-align:justify;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText><b><span lang=TR style='font-size:14.0pt;line-height:150%;
font-family:Tahoma;mso-ansi-language:TR'>Kafa Kemi&#287;i
K&#305;r&#305;klar&#305;</span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Kuzey Amerika ve Avrupa
�lkelerinde yap&#305;lan istatistiklere g�re, �zellikle �ocuklarda&nbsp; kafa kemi&#287;i
k&#305;r&#305;klar&#305;n&#305;n %90�n&#305;n&#305; lineer k&#305;r&#305;klar
olu&#351;turmaktad&#305;r. Tan&#305; i�in en duyarl&#305; y�ntem direkt
kranyografilerdir. Buna kar&#351;&#305;n, kaide k&#305;r&#305;klar&#305; direkt
kranyografi ile g�sterilemeyebilir. Ayr&#305;ca BT, zaman zaman lineer
k&#305;r&#305;klar&#305; ka�&#305;rabilse de, as&#305;l �nemli olan beyin
parenkim hasar&#305; hakk&#305;nda yeterli bilgiyi vermektedir. Bu nedenle
g�n�m�zde, kafa travmas&#305; sonras&#305; g�r�nt�leme i�in BT ilk se�ilmesi
gereken y�ntemdir. Aksiyel kesitlere paralel bir lineer k&#305;r&#305;k atlansa
dahi buna ba&#287;l&#305; bir komplikasyon geli&#351;medi&#287;i
bildirilmektedir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent style='text-indent:35.4pt;line-height:150%'><b><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>&nbsp;</span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyTextIndent style='text-indent:0cm;line-height:150%'><b><span
lang=TR style='font-size:12.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>Lineer k&#305;r&#305;klar:&nbsp; </span></b><span lang=TR style='font-size:
12.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:TR'>Lineer
k&#305;r&#305;klar genellikle �zel bir tedavi gerektirmez. Ancak ortada ciddi
bir travma oldu&#287;unu ve n�rolojik muayenesi normal hastalarda bile,
k&#305;r&#305;k saptanmas&#305;n&#305;n, intrakranyal kanama ihtimalini y�z kat
artt&#305;rd&#305;&#287;&#305;n&#305; g�z �n�ne almak gerekir. Kranyal BT�de ek
bir patolojinin saptanmad&#305;&#287;&#305; izole lineer frakt�rl� hastalar ise
bir �ok merkezde evde izlenmek �zere �nerilerle taburcu edilmektedir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>��kme
k&#305;r&#305;klar&#305;: </span></b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'>��kme k&#305;r&#305;klar&#305; genellikle d�&#351;meler
veya fokal darbeler sonucu ortaya �&#305;kt&#305;&#287;&#305;ndan bilin�
kayb&#305; pek g�r�lmez. Yenido&#287;anlarda ise, �o&#287;unlukla
d�&#351;melere ba&#287;l&#305; olarak, alt y�zeyin yumu&#351;ak oldu&#287;u
�ping-pong� k&#305;r&#305;&#287;&#305; olarak da adland&#305;r&#305;lan, beyin
parenkiminin genellikle normal oldu&#287;u ��kme k&#305;r&#305;klar&#305;
s&#305;k g�r�l�r. ��kme k&#305;r&#305;klar&#305; palpasyonla tan&#305;nabilirse
de subgaleal hematomlar aldat&#305;c&#305; olabilir. Tan&#305; i�in kranyal BT
g�n�m�zde en uygun se�imdir. Cerrahi tedavi indikasyonunun konmas&#305;nda ve
uygun y�ntemin se�iminde ��kme frakt�r�n�n yeri, ��kmenin miktar&#305;, cildin
durumu ve hastan&#305;n genel klinik tablosu g�z �n�ne al&#305;n&#305;r. Genel
olarak kemi&#287;in t�m kal&#305;nl&#305;&#287;&#305;n&#305; a&#351;an
��kmelerin cerrahi olarak d�zeltilmesi gerekti&#287;i kabul edilir. Ayr&#305;ca
estetik kusura ya da beyin omurilik s&#305;v&#305;s&#305; (BOS) veya beyin
parenkim fist�l�ne neden olan ��kme k&#305;r&#305;klar&#305; da ameliyat
edilmelidir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Kafa taban&#305;
k&#305;r&#305;klar&#305;: </span></b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'>Yaral&#305;n&#305;n hastaneye yat&#305;r&#305;lmas&#305;
ve menenjit, BOS fist�l� ve kranyal sinir (�zellikle I, II, VII, VIII.
sinirler) bulgular&#305; a�&#305;s&#305;ndan takip edilmesi gerekir.
Profilaktik antibiotik kullan&#305;m&#305; hakk&#305;nda g�r�&#351;
birli&#287;i sa&#287;lanamam&#305;&#351;t&#305;r. Kendili&#287;inden d�zelmeyen
BOS fist�llerine ya da kranyal sinir (�zellikle II.sinir) dekompresyonuna
y�nelik cerrahi giri&#351;imler gerekebilir . </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>B�y�yen
k&#305;r&#305;klar (leptomeningeal kistler): </span></b><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>T�m k&#305;r&#305;klar&#305;n
yakla&#351;&#305;k %1�inde rastlan&#305;r. Genellikle 3 ya&#351;&#305;n
alt&#305;ndaki �ocuklarda, dura ve parenkimde yaralanmaya yol a�acak,
�o&#287;unlukla aras&#305; 3 mm�den fazla, ciddi konveksite
k&#305;r&#305;klar&#305;ndan sonra g�r�l�r.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-size:14.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>Delici Cisimle Yaralanmalar</span></b><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Yeti&#351;kinlerde ate&#351;li
silahla yaralanmalar s&#305;kken, kemi&#287;i hen�z yeterince
geli&#351;memi&#351; olan �ocuklarda tornavida, �ivi, t&#305;&#287; gibi
cisimlerle, kolayca delici yaralanmalar g�r�lebilir. Transorbital yaralanmalar
da �ocukluk �a&#287;&#305;nda s&#305;kt&#305;r. Parenkim hasar&#305; ve
arterioven�z fist�l, ps�doanevrizma gibi vask�ler komplikasyonlar y�n�nden
gerekli radyolojik incelemeler yap&#305;lmal&#305;, infeksiyonu �nlemek i�in
�zenli bir yara debridman&#305; ve k&#305;sa s�reli antibiotik profilaksisi
uygulanmal&#305;d&#305;r. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<h1 style='text-indent:0cm'><span lang=TR style='font-size:14.0pt;line-height:
150%;font-family:Tahoma;mso-ansi-language:TR;text-decoration:none;text-underline:
none'>&#304;ntrakranyal Lezyonlar</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></h1>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<h4 style='text-indent:0cm'><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>Akut Epidural Hematomlar (EDH)</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></h4>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>T�m EDH�lar&#305;n
yakla&#351;&#305;k %60�&#305;n&#305;n 20 ya&#351;&#305;n alt&#305;nda,
�zellikle de trafik kazas&#305; ge�irmi&#351; erkeklerde, g�r�ld�&#287;�
bildirilmektedir (<b>&#350;ekil 1</b>). Akut EDH�nin yava&#351;
geli&#351;ebilece&#287;ini, <i>bilin� kayb&#305; - lusid interval - bilin�te
k�t�le&#351;me, hemiparezi ve anizokori</i>den olu&#351;an klasik seyrin
g�r�lmeyebilece&#287;ini unutmamak gerekir. Genellikle k&#305;r&#305;k
hatt&#305;n&#305;n, meningea media arterini �aprazlad&#305;&#287;&#305;
yerlerde g�r�l�r ve tedavinin ba&#351;ar&#305;s&#305; hastan&#305;n ameliyat
�ncesi n�rolojik durumuyla do&#287;rudan ili&#351;kilidir. EDH�larda genelde
kabul g�ren cerrahi tedavi indikasyonlar&#305; a&#351;a&#287;&#305;da
�zetlenmi&#351;tir:</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:53.4pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span lang=TR style='font-family:Symbol;mso-ansi-language:
TR'>�</span><span lang=TR style='font-size:7.0pt;line-height:150%;mso-ansi-language:
TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Fokal n�rolojik bulgu, bilin�
bozuklu&#287;u</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:53.4pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span lang=TR style='font-family:Symbol;mso-ansi-language:
TR'>�</span><span lang=TR style='font-size:7.0pt;line-height:150%;mso-ansi-language:
TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Belirgin korteks
bas&#305;s&#305; (genellikle 15mm�den fazla kal&#305;nl&#305;k)</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:53.4pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span lang=TR style='font-family:Symbol;mso-ansi-language:
TR'>�</span><span lang=TR style='font-size:7.0pt;line-height:150%;mso-ansi-language:
TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>30-35 ml�yi ge�en hacim</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:53.4pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span lang=TR style='font-family:Symbol;mso-ansi-language:
TR'>�</span><span lang=TR style='font-size:7.0pt;line-height:150%;mso-ansi-language:
TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>�zellikle temporal lob
yerle&#351;imli, orta hatta itilmeye veya unkal herniasyona yol a�an hematom</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:53.4pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span lang=TR style='font-family:Symbol;mso-ansi-language:
TR'>�</span><span lang=TR style='font-size:7.0pt;line-height:150%;mso-ansi-language:
TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>E&#351;lik eden intraparenkimal
lezyon veya kitle etkisi olan subdural hematom</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Ayr&#305;ca arka �ukur
EDH�lar&#305;nda daha d�&#351;�k bir hacim, 4. ventrik�l bas&#305;s&#305;,
ventrik�ler dilatasyon gibi kriterlerin g�z �n�ne al&#305;nmas&#305; gerekir.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<h2 style='margin-left:35.4pt;text-indent:35.4pt'><b><span lang=TR
style='font-size:10.0pt;line-height:150%;font-family:Tahoma;color:blue;
mso-ansi-language:TR;font-style:normal;text-decoration:none;text-underline:
none'>&nbsp;</span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></h2>

<h2 style='text-indent:35.4pt'><b><span lang=TR style='font-size:10.0pt;
line-height:150%;font-family:Tahoma;color:blue;mso-ansi-language:TR;font-style:
normal'><a href="travma1.jpg">&#350;ekil 1.</a></span></b><b><span lang=TR
style='font-size:10.0pt;line-height:150%;font-family:Tahoma;color:blue;
mso-ansi-language:TR;font-style:normal;text-decoration:none;text-underline:
none'> </span></b><span lang=TR style='font-size:10.0pt;line-height:150%;
font-family:Tahoma;mso-ansi-language:TR;font-style:normal;text-decoration:none;
text-underline:none'>Akut epidural hematom</span></h2>

<h2 style='text-indent:35.4pt'><b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR;font-style:normal;text-decoration:none;text-underline:
none'>&nbsp;</span></b></h2>

<h2 style='text-indent:0cm'><b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR;font-style:normal;text-decoration:none;text-underline:
none'>Akut Subdural Hematomlar (ASDH)</span></b></h2>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>ASDH�li hastalar&#305;n </span><span lang=TR style='font-family:Symbol;
mso-ansi-language:TR'>%</span><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR'>42-50�sinde yaralanmadan itibaren bilincin kapal&#305;
oldu&#287;u ve hastalar&#305;n yakla&#351;&#305;k yar&#305;s&#305;n&#305;n
komadan �&#305;kamad&#305;&#287;&#305; bildirilmi&#351;tir. Ameliyat �ncesi
d�nemde, hastan&#305;n GKS�si ne kadar d�&#351;�kse, mortalite de o oranda
y�ksektir. Ayr&#305;ca ya&#351;, pupilla anomalisi, parezi, artm&#305;&#351;
intrakranyal bas&#305;n� (&#304;KB), hematomun hacmi, hematoma e&#351;lik eden
di&#287;er intrakranyal ve ekstrakranyal lezyonlar ile ameliyat
zamanlamas&#305; mortaliteye etki eden �nemli fakt�rlerdir (<b>&#350;ekil 2</b>).
Genel olarak, BT�de kal&#305;nl&#305;&#287;&#305; 10mm�yi a&#351;an veya orta
hatta 5mm�den fazla itilmeye yol a�an ASDH�lerin, hastan&#305;n GKS�si ne
olursa olsun, ameliyat edilmesi �nerilir. GKS�si 9�dan k�t� hastalarda, hematom
kal&#305;nl&#305;&#287;&#305; veya orta hattaki itilme ne olursa olsun
anizokori varl&#305;&#287;&#305;nda, intrakranyal bas&#305;n� 20mm Hg�nin
�zerine �&#305;kt&#305;ysa veya travma sonras&#305; izlemde GKS�de iki veya
daha fazla puanl&#305;k d�&#351;�&#351; olduysa, yine ameliyat gereklidir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='margin-left:35.4pt;text-indent:35.45pt'><b><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma;color:blue;
mso-ansi-language:TR'>&nbsp;</span></b><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:35.4pt'><b><u><span lang=TR
style='font-size:10.0pt;line-height:150%;font-family:Tahoma;color:blue;
mso-ansi-language:TR'><a href="travma2a.jpg">&#350;ekil 2a</a> </span></u></b><b><u><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>ve<span style='color:blue'> <a href="travma2b.jpg">&#350;ekil 2b</a>.</span></span></u></b><span
lang=TR style='font-size:10.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'> Akut subdural hematomlu olgu �rnekleri </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:35.4pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoBodyText><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR'>K&#304;BAS ve hemisferik &#351;i&#351;me, ASDH�li hastalar&#305;n gerek
ameliyat s&#305;ras&#305;nda gerekse ameliyat sonras&#305; takibinde,
n�ro&#351;ir�rji uzmanlar&#305;n&#305;n s&#305;k kar&#351;&#305;la&#351;t&#305;klar&#305;
komplikasyonlard&#305;r ve ASDH�li hastalarda mortalitenin belirleyici
fakt�rleridir. Bu nedenle akut subdural hematomu olan t�m komal&#305;
hastalarda (GKS&lt;9) intrakranyal bas&#305;n� monit�rizasyonu �nerilmektedir.
Bu komplikasyonlar&#305;n olu&#351;umunda, hematomun alttaki korteks �zerine
etki etmesi sonucu geli&#351;en iskeminin �nemli rol� oldu&#287;u g�r�&#351;�
savunulmaktad&#305;r. &#304;lk 4 saatte ameliyat edilmi&#351; ASDH�li
hastalarda prognozun daha iyi olmas&#305; da yine bu g�r�&#351;�
desteklemektedir.</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><b><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Kronik Subdural Hematom
(KSDH)</span></b><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>KSDH, n�ro&#351;ir�rji
prati&#287;inde s&#305;k rastlanan, d�&#351;�k morbidite ve mortaliteye sahip,
tedavisi olduk�a kolay bir patolojidir. Ya&#351;l&#305;larda beyin
a&#287;&#305;rl&#305;&#287;&#305;nda yakla&#351;&#305;k 200g azalma ve
ekstraserebral hacimde %11 oran&#305;nda art&#305;&#351; meydana gelmesine
ba&#287;l&#305; olarak genellikle orta ya&#351;tan sonra ve �zellikle ileri
ya&#351;ta g�r�len bir hastal&#305;kt&#305;r. Genelde akut subdural hematomdan
geli&#351;ti&#287;i d�&#351;�n�lse de, ge�irilmi&#351; travma �yk�s�
vakalar&#305;n %50-70�inde, hatta kimi serilere g�re %50�sinden az&#305;nda
mevcuttur. Di&#287;er olas&#305; nedenler aras&#305;nda, a&#351;&#305;r&#305;
alkol kullan&#305;m&#305;, epilepsi, &#351;ant ameliyatlar&#305;, araknoid
kistler ve koag�lopatiler say&#305;labilir. Olgular&#305;n %15-25�inde KSDH iki
tarafl&#305;d&#305;r.&nbsp; </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>KSDH, duran&#305;n
alt&#305;nda, bir i� ve d&#305;&#351; membran aras&#305;nda olu&#351;mu&#351;
kanla dolu bir bo&#351;luk olarak tan&#305;mlanabilir. D&#305;&#351; membran,
kolayca zedelenen ve tekrarlay&#305;c&#305; fokal kanamalarla hematomun
b�y�mesine yol a�an sinuzoidal damarlardan zengindir. P&#305;ht&#305;la&#351;ma
fakt�rleri ile fibrinolitik ajanlar aras&#305;ndaki uyumsuzlu&#287;un veya
hematomdan y�ksek miktarda salg&#305;lanan doku tipi plazminojen aktivat�r�n�n
hematomun koag�lasyonunu �nledi&#287;i d�&#351;�n�lmektedir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Klinik tablo hafiften
a&#287;&#305;ra farkl&#305; &#351;ekillerde g�r�lebilir. Hastalar
ba&#351;a&#287;r&#305;s&#305;, konf�zyon, konu&#351;ma g��l�&#287;� gibi
yak&#305;nma ve bulgularla ya da ge�ici iskemik ataklar&#305; and&#305;ran
bulgularla ba&#351;vurabilir. Daha a&#287;&#305;r durumlarda n�bet (genellikle
fokal), hemipleji veya koma g�r�lebilir. Ya&#351;l&#305;larda kognitif
fonksiyon kay&#305;plar&#305;n&#305;n daha s&#305;k g�r�ld�&#287;�, buna
kar&#351;&#305;l&#305;k gen�lerde ba&#351;a&#287;r&#305;s&#305; gibi
artm&#305;&#351; kafai�i bas&#305;n� bulgular&#305;n&#305;n �n plana
�&#305;kt&#305;&#287;&#305; bildirilmektedir.&nbsp; </span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Tan&#305; i�in
ba&#351;vurulacak g�r�nt� y�ntemleri aras&#305;nda h&#305;zl&#305; ve kolay
ula&#351;&#305;labilir olu&#351;uyla kranyal BT ilk se�imdir. KSDH
�o&#287;unlukla hipodens olarak izlenmesine ra&#287;men bazen izo-hatta
hiperdens olarak izlenebilir; ayn&#305; hematomda farkl&#305; kanama evrelerine
ba&#287;l&#305; olarak farkl&#305; densiteler g�r�lebilir. �zellikle izodens
hematomlar&#305; g�zden ka�&#305;rmamak i�in �ok dikkatli olmak, kortikal
sulkuslar&#305;n nerede sonland&#305;&#287;&#305; gibi ipu�lar&#305;ndan
yararlanmak gerekir. Kranyal MR, hem izodens hematomlar&#305;n hem de hematom
i�indeki farkl&#305; evrelerdeki kanamalar&#305;n ayr&#305;nt&#305;l&#305;
g�r�nt�lenmesinde ve buna ba&#287;l&#305; olarak ameliyat stratejisinin
belirlenmesinde yararl&#305;d&#305;r (<b>&#350;ekil 3</b>). </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:35.4pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:35.4pt'><b><u><span lang=TR
style='font-size:10.0pt;font-family:Tahoma;color:blue;mso-ansi-language:TR'><a
href="travma3a.jpg">&#350;ekil 3a</a></span></u></b><b><u><span lang=TR
style='font-size:10.0pt;font-family:Tahoma;mso-ansi-language:TR'> ve <span
style='color:blue'><a href="travma3b.jpg">&#350;ekil 3b</a></span></span></u></b><span
lang=TR style='font-size:10.0pt;font-family:Tahoma;mso-ansi-language:TR'>.
Kranyal BT incelemesinde (3a) yer yer izo-hipo-ve hiperdens g�r�len, kitle
etkisiyle lateral ventrik�l� silmi&#351; bir kronik subdural hematom. Ayn&#305;
hastan&#305;n kranyal MR incelemesinde (3b) hematom i�erisinde �e&#351;itli
evrelerdeki kanamalar daha net g�r�lmektedir.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Asemptomatik ve ince hematomu
olan (orta hatta itilmeye yol a�mam&#305;&#351;, 1cm�den ince) hastalarda
kortikosteroid ve/veya mannitolle medikal tedavi uygulanabilmesine ra&#287;men
KSDH�&#305;n tedavisi genellikle cerrahidir. N�betin intrakranyal
bas&#305;nc&#305; artt&#305;rarak herniasyona yol a�abilme ihtimali ve ge�
d�nem epilepsi oran&#305;n&#305; d�&#351;�rmesi olas&#305;l&#305;&#287;&#305;
gibi nedenlerden dolay&#305; bir�ok n�ro&#351;irurji merkezi profilaktik
antiepileptik ila� kullan&#305;m&#305;n&#305; tercih etmektedir. Cerrahi
tedavide �e&#351;itli se�enekler olmas&#305;na kar&#351;&#305;n en s&#305;k
uygulanan y�ntem iki delikle hematomun bo&#351;alt&#305;lmas&#305; ve kavitenin
y&#305;kanmas&#305;d&#305;r. Genellikle ameliyat sonras&#305;nda klinik tablo
h&#305;zla d�zelir. Erken d�nem kontrol kranyal BT�ler hemen her zaman bir
miktar hematomun devam etti&#287;ini g�sterece&#287;inden tedavinin
ba&#351;ar&#305;s&#305;na hastan&#305;n klinik durumuna g�re karar vermek
gerekir. Ameliyat sonras&#305; d�nemdeki en �nemli problemlerden biri hematomun
yeniden toplanmas&#305;d&#305;r ve �zellikle �ok ya&#351;l&#305;larda, genel
durumu k�t� olanlarda, serebral atrofisi ya da �ok b�y�k hematomu olanlarda, b�brek
ya da karaci&#287;er hastal&#305;&#287;&#305; olanlarda, antikoagulan
kullananlarda ve farkl&#305; evrelerde kanamas&#305; olanlarda daha s&#305;k
g�r�l�r. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoBodyText style='text-indent:35.4pt'><span lang=TR style='font-family:
Tahoma;mso-ansi-language:TR'>&nbsp;</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<h2 style='text-indent:0cm'><b><span lang=TR style='font-family:Tahoma;
mso-ansi-language:TR;font-style:normal;text-decoration:none;text-underline:
none'>&#304;ntraserebral Hematomlar</span></b><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></h2>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&#304;ntraserebral kanama
a&#287;&#305;r kafa travmas&#305;n&#305;n s&#305;k g�r�len ve zaman zaman
cerrahi m�dahale gerektiren bir sekelidir. Minik bir kont�zyondan veya diff�z
aksonal hasardaki mikroskobik bir kanamadan dev bir hematoma ula&#351;an
geni&#351; bir spektrumda g�r�lebilirler. Tedavi i�in genel K&#304;BAS tedavi
ilkeleri uygulanmal&#305;d&#305;r.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<h6 style='text-indent:0cm'><span lang=TR style='font-family:Tahoma;mso-ansi-language:
TR;text-decoration:none;text-underline:none'>Kaza Olmayan Beyin Travmalar&#305;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></h6>

<p class=MsoBodyTextIndent2 style='text-indent:0cm'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>�ocuk suiistimali,
sallanm&#305;&#351; bebek ya da d�v�lm�&#351; bebek sendromu gibi adlar da
verilen kaza olmayan beyin travmalar&#305; son 20 y&#305;lda giderek daha fazla
�nem kazanm&#305;&#351;t&#305;r. Kuzey Amerika istatistiklerine g�re iki
ya&#351;&#305;n alt&#305;ndaki beyin yaralanmalar&#305;n&#305;n %10�u, bir
ya&#351;&#305;n alt&#305;ndakilerin ise yakla&#351;&#305;k %50�si kaza
d&#305;&#351;&#305; travmalara ba&#287;l&#305;d&#305;r. �lkemizdeki durumu,
sa&#287;l&#305;kl&#305; olarak de&#287;erlendirmek m�mk�n olmasa da, �ok
farkl&#305; oldu&#287;unu d�&#351;�nmek i�in bir neden yoktur. Hastaneye
getirilen �ocuklarda bilin� bozuklu&#287;u, n�bet, K&#304;BAS bulgular&#305;,
ya&#351;amsal bulgularda bozukluklar ve kafatas&#305; k&#305;r&#305;klar&#305;
g�r�lebilir. Retinal kanamalar, v�cudun �e&#351;itli yerlerinde farkl&#305;
evrelerde morluklar ve yan&#305;k izleri saptanabilir. Genellikle yaralanmalar
hakk&#305;nda tatmin edici anamnez al&#305;namaz. Retinal kanamalar&#305;,
farkl&#305; evrelerde subdural hematomlar&#305;, a�&#305;klanmas&#305; zor
fiziksel yaralanmalar&#305; olan bir �ocukla
kar&#351;&#305;la&#351;&#305;ld&#305;&#287;&#305;nda resmi makamlar&#305;
haberdar etmeyi ihmal etmemek gerekir.</span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
lang=TR style='font-size:14.0pt;line-height:150%;font-family:Tahoma;mso-ansi-language:
TR'>A&#287;&#305;r Kafa Travmas&#305;nda Tedavi Prensipleri</span></b><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>A&#287;&#305;r ve hatta orta
&#351;iddette kafa travmas&#305; hastan&#305;n yo&#287;un bak&#305;m birimine
yat&#305;r&#305;lmas&#305;n&#305; gerektirir. Hasta yo&#287;un bak&#305;ma
al&#305;n&#305;rken GKS�yi, pupil b�y�kl�&#287;�n� ve &#305;&#351;&#305;k
cevab&#305;n&#305;, g�z hareketlerini, ekstremitelerin a&#287;r&#305;ya
cevab&#305;n&#305; ve beyinsap&#305; reflekslerini i�eren bir n�rolojik
de&#287;erlendirme genellikle yeterli bilgiyi verir. Bu s&#305;rada rutin
res�sitasyon i&#351;leminin (ABC) h&#305;zla ve �zenle ger�ekle&#351;tirilmesi
ikincil beyin hasarlar&#305;n&#305;n �nlenmesinde de yard&#305;mc&#305; olur.
Bir taraftan da akci&#287;er ve kalp kont�zyonlar&#305;, dalak r�pt�r� gibi
sistemik yaralanmalar ve k&#305;r&#305;klar&#305; g�zden ka�&#305;rmamak i�in
h&#305;zl&#305; bir fizik muayene yapmak gerekir. Hipotansiyon genellikle
kanamaya ba&#287;l&#305; hipovolemiye i&#351;aret eder ve a&#287;&#305;r kafa
travmas&#305;n&#305;n bulgusu de&#287;ildir. Sadece beyin �l�m�nde, belirgin
omurilik hasar&#305;nda ve k���k �ocuklardaki intrakranyal kanama ile hipotansiyon
g�r�lebilir. Burada yenido&#287;an ve s�t �ocuklar&#305;n&#305;n subgaleal bir
hematom ile bile hipovolemik &#351;oka girebileceklerini unutmamak gerekir.
Serebral perf�zyonun korunabilmesi i�i mutlaka yeterli s&#305;v&#305;
replasman&#305; sa&#287;lanmal&#305;, s&#305;v&#305;
k&#305;s&#305;tlamas&#305;ndan &#351;iddetle ka�&#305;n&#305;lmal&#305;d&#305;r.
</span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>A&#287;&#305;r kafa
travmas&#305;nda yap&#305;lacak i&#351;lemler, g�n�m�zde genellikle Kuzey
Amerika ve Avrupa�daki Kafa Travmas&#305; Vak&#305;flar&#305;n&#305;n
yay&#305;nlad&#305;&#287;&#305; tedavi ilkelerine g�re y�r�t�lmektedir. Bunlara
g�re, bug�n a&#287;&#305;r kafa travmal&#305; hastan&#305;n getirildi&#287;i
n�rotravma merkezinde yap&#305;lacak ilk i&#351;lem, cerrahi boyuttaki
kitlelerin bo&#351;alt&#305;lmas&#305; d&#305;&#351;&#305;nda, intrakranyal
bas&#305;n� (&#304;KB) monit�rizasyonu olmal&#305;d&#305;r. Bunun i�in
parenkimal problar kullan&#305;labilece&#287;i gibi, gerekti&#287;inde BOS
drenaj&#305;na olanak veren intraventrik�ler kateterler de se�ilebilir.
Monit�rizasyon sa&#287;land&#305;ktan sonra tedavi, &#304;KB�nin kontrol� ve
yeterli serebral perf�zyon bas&#305;nc&#305;n&#305;n (SPB)
sa&#287;lanmas&#305;na y�nelik olarak &#351;ekillendirilebilir. &#304;lk
olarak, ate&#351; kontrol�, juguler ven�z d�n�&#351;�n rahatlat&#305;lmas&#305;
ve yeterli oksijenasyonun sa&#287;lanmas&#305; gibi baz&#305; genel �nlemlerin
al&#305;nmas&#305; gerekir. Ba&#351;lang&#305;�ta PaCO<sub>2</sub> normal
de&#287;erin alt s&#305;n&#305;r&#305;nda (yakla&#351;&#305;k 35mmHg)
tutulmal&#305;d&#305;r. Ayr&#305;ca, &#304;KB ne olursa olsun, yeterli SPB�nin
sa&#287;land&#305;&#287;&#305;ndan emin olunmal&#305;d&#305;r.</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>K&#304;BAS
saptand&#305;&#287;&#305;nda �ncelikle sedasyon ve analjezi kontrol edilmeli,
gerekirse artt&#305;r&#305;lmal&#305;d&#305;r. Hasta �volemikse,
yata&#287;&#305;n ba&#351;&#305; yakla&#351;&#305;k 30<sup>0 </sup>kald&#305;r&#305;l&#305;r
ve &#304;KB�yle SPB g�zlenerek etkisi beklenir. Tedaviye n�rom�sk�ler inhibit�r
ekleme se�ene&#287;i de bu a&#351;amada de&#287;erlendirilmelidir. </span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>N�rom�sk�ler inhibisyon olsun
olmas&#305;n sedasyon, analjezi ve yata&#287;&#305;n ba&#351;&#305;n&#305;n
y�kseltilmesi gibi �nlemlere ra&#287;men &#304;KB y�ksek seyretmeye devam
etti&#287;i takdirde uygulanacak ilk giri&#351;im BOS drenaj&#305; olmal&#305;d&#305;r.
E&#287;er &#304;KB monit�rizasyon cihaz&#305; buna uygun de&#287;ilse, ventrik�l
drenaj&#305; denenebilir. </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:35.4pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>BOS drenaj&#305; &#304;KB
kontrol�nde yeterli olmazsa hiperozmolar tedavi d�&#351;�n�lmelidir. Bu ama�la
bug�n mannitol�n yan&#305; s&#305;ra hipertonik tuz ��zeltileri de
kullan&#305;lmaktad&#305;r. Bu tedavi s&#305;ras&#305;nda hem hastan&#305;n s&#305;v&#305;
dengesi, hem de kan osmolaritesi yak&#305;ndan izlenmelidir. Hiperozmolar
tedavi yetersiz kal&#305;rsa ventilasyon artt&#305;r&#305;larak PaCO<sub>2</sub>
30 mmHg d�zeyine dek d�&#351;�r�lebilir. Hiperventilasyon
uyguland&#305;&#287;&#305;nda serebral kan ak&#305;m&#305; ve juguler ven�z
saturasyonun takibi gereklidir. </span><span lang=TR style='mso-ansi-language:
TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:42.55pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Artm&#305;&#351; &#304;KB�nin
tedavisi s&#305;ras&#305;nda her zaman hastada ameliyat edilmesi gereken yeni
bir kitle lezyonunun geli&#351;mi&#351; olabilece&#287;i unutulmamal&#305;,
tedaviye yeterli cevap al&#305;namad&#305;&#287;&#305; veya &#304;KB�nin
kontrolden �&#305;kt&#305;&#287;&#305; durumlarda mutlaka BT tekrar
edilmelidir.&nbsp; </span><span lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:42.55pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>Yukar&#305;da belirtilen t�m
tedavilere cevap al&#305;namad&#305;&#287;&#305; durumlarda, doktor da
hastan&#305;n &#304;KB�nin d�&#351;mesinden yarar g�rece&#287;ini
d�&#351;�n�yorsa, ikinci s&#305;ra tedavi y�ntemleri d�&#351;�n�lebilir. Y�ksek
doz barbit�rat komas&#305;, tek veya iki tarafl&#305; kranyektomi ve
duroplasti, ciddi hiperventilasyon (PaCO<sub>2</sub> &lt;30 mmHg) ve
&#305;l&#305;ml&#305; hipotermi (32-34<sup>0</sup>C) gibi, zaman zaman
yararl&#305; oldu&#287;u y�n�nde yay&#305;nlar yap&#305;lan, ancak geni&#351;
ve kar&#351;&#305;la&#351;t&#305;rmal&#305; �al&#305;&#351;malarda hen�z kesin
yarar&#305; kan&#305;tlanamam&#305;&#351; y�ntemlerin se�im ve uygulanmas&#305;n&#305;
daha �ok sorumlu doktora b&#305;rakmak uygun olur.</span><span lang=TR
style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;text-indent:42.55pt;line-height:
150%'><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>&nbsp;</span><span
lang=TR style='mso-ansi-language:TR'><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><b><span
style='font-size:14.0pt;line-height:150%;font-family:Tahoma'>Kaynaklar</span></b></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>1.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Atkinson JLD: Traumatic intracerebral hematoma.
&#304;�inde: Textbook of Neurological Surgery<i>.</i> Batjer HH, Loftus CM
(Edit�rler). Lippincott, Williams&amp;Wilkins, Baltimore, 2002: 2846-2851</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>2.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Bullock MR, Chesnut R,
Ghajar J, Gordon D</span><span style='font-family:Tahoma'> ve ark. Surgical
management of acute subdural hematomas. Neurosurgery 2006;58: S2-S24</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>3.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Bullock MR, Povlishock JT. Guidelines for the
management of severe traumatic brain injury. J Neurotrauma 2007; 24: Supplement
1 </span><span lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>S1-98</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>4.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Carney NA, Chesnut R, Kochanek PM, American
Association for Surgery of Trauma; Child Neurology Society; International
Society for Pediatric Neurosurgery; International Trauma Anesthesia and
Critical Care Society; Society of Critical Care Medicine; World Federation of
Pediatric Intensive and Critical Care Societies. Guidelines for the acute
medical management of severe traumatic brain injury in infants, children, and
adolescents. Pediatr Crit Care Med 2003;4(3 Suppl): </span><span lang=TR
style='font-family:Tahoma;mso-ansi-language:TR'>S1-491</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>5.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Flannery AM, Houle P. Epidural hematoma. &#304;�inde:
Textbook of Neurological Surgery. Batjer HH, Loftus CM (edit�rler). Lippincott,
Williams&amp;Wilkins, Baltimore 2002:1091-1095</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>6.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Gelabert-Gonzalez M, Iglesias-Pais M, Garcia-Allut
A, Martinez-Rumbo R. Chronic subdural haematoma: Surgical treatment and outcome
in 1000 cases. Clin Neurol Neurosurg 2005; 107: 223-9</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>7.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Hsiang JN, Yeung T, Yu AL, Poon WS. High-risk mild
head injury. J Neurosurg 1997; 87:234-8</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>8.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
lang=TR style='font-family:Tahoma;mso-ansi-language:TR'>Jagoda AS, Bazarian JJ,
Bruns JJ Jr, Cantrill SV</span><span style='font-family:Tahoma'> ve ark.
Clinical policy: Neuroimaging and decision making in adult mild traumatic brain
injury in the acute setting. Ann Emerg Med 2008; 52: 714-748</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>9.</span><span
style='font-size:7.0pt;line-height:150%'>&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-family:Tahoma'>Jennett B: Epidemiology of head injury. J Neurol
Neurosurg Psychiatry 1996; 60: 362-369</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>10.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>Keskil
IS, Baykaner MK, Ceviker N, Kaymaz M. Assessment of mortality associated with
mild head injury in the pediatric age group. Childs Nerv Syst 1995; 11:467-473</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>11.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>Proctor
MR, Barrow MC. Neurosurgical aspects of nonaccidental travma in children.
&#304;�inde: Textbook of Neurological Surgery. Batjer HH, Loftus CM
(Edit�rler). Lippincott, Williams&amp;Wilkins, Baltimore 2002: 1065-1072</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>12.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>Rivara
FP: Pediatric injury control in 1999: Where do we go from here? Pediatrics
1999; 103:883-888</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>13.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>&nbsp;Robertson
C: Critical care management of traumatic brain injury. &#304;�inde: Marshall LF
and Grady MS (Edit�rler). Youmans Neurological Surgery, 2004, D�rd�nc� cilt,
Saunders, Philadelphia :5065-5081</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>14.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>Servadei
F, Merry GS: Mild head injury in adults. &#304;�inde: Marshall LF and Grady MS
(Edit�rler). Youmans Neurological Surgery, 2004, D�rd�nc� cilt, Saunders,
Philadelphia :5065-5081</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>15.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>Tong
KA, Ashwal S, Holshouser BA, Shutter LA, ve ark. Hemorrhagic shearing lesions
in children and adolescents with posttraumatic diffuse axonal injury: improved
detection and initial results. Radiology 2003;&nbsp; 227:332-339</span></p>

<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent:
-18.0pt;line-height:150%'><span style='font-family:Tahoma'>16.</span><span
style='font-size:7.0pt;line-height:150%'> </span><span style='font-family:Tahoma'>Wijdicks
EFM: Traumatic brain injury. &#304;�inde: The Clinical Practice of Critical
Care Neurology. Oxford University Press; New York 2003: 369-388</span></p>

</div>

</body>

</html>
